Michelle Yong
@michyong2
ID physician, CMV & viral infections, Clinician researcher, @NCICancer @PeterMacCC @TheRMH @TheDohertyInst
You might like
Great meeting and really fantastic to see lots of NCIC works mentioned by current and future collaborators. @c_garciavidal @FannyLanternier @michyong2 @monicaslavin
#Interferon-α #Nasal Spray #Prophylaxis Reduces #COVID19 in #Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial academic.oup.com/cid/article/do…
In the ITT population, the overall incidence of COVID-19 infection was 11.3% in the interferon-α arm. #COVID19 | @michyong2 cancernetwork.com/view/interfero…
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients, Double-Blinded, Placebo-RCT; Oxford Academic. incidence of COVID19 was⬇️ in IFN-α group versus placebo (8.3% vs 14.4%), 40%⬇️ risk of infection ([RR]: .60). academic.oup.com/cid/advance-ar…
Remarkable. Double blind placebo controlled trial shows large reduction in COVID-19 incidence and limited fanfare. Really is 2025. Imagine same thing in 2020. Very impressive trial. High rates of COVID-19.
🔥🔥Just published in #CID world-first clinical trial of IFN-a nasal spray vs placebo reduced #COVID 🦠 incidence 📉 by 40% in cancer pts. Well tolerated, safe, effective… Full link here: academic.oup.com/cid/advance-ar…
👃Interferon-α Nasal Spray Prophylaxis Reduces #COVID-19 in #Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial academic.oup.com/cid/article/do…
Study: Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial. Published: 28 August 2025 Source: academic.oup.com/cid/advance-ar…
Australian-led trial shows nasal spray reduces COVID-19 risk in cancer patients The research showed a nasal spray with interferon-alpha (IFN-α), a natural protein with broad antiviral activity, can reduce COVID infection risk by 40% compared with placebo. petermac.org/about-us/news-…
Our work at COVIDhge showed 🧬mutations or auto-Abs to type I IFN caused severe COVID, suggesting IFN could be used against COVID. Now, an RCT proves IFN📉 COVID👇🏼: Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients academic.oup.com/cid/article/do…
A world-first clinical trial at Peter Mac has found that a simple nasal spray can significantly reduce the risk of COVID-19 in cancer patients. Research published today showed the spray reduced the risk of COVID-19 infection by 40%. Read more here - bit.ly/3JBAjW8
🔥🔥Just published in #CID world-first clinical trial of IFN-a nasal spray vs placebo reduced #COVID 🦠 incidence 📉 by 40% in cancer pts. Well tolerated, safe, effective… Full link here: academic.oup.com/cid/advance-ar…
Interesting data re: autoAbs @donaldvinh . The IFN group had reduced COVID incidence by 40%. Participants reported being asymptomatic whilst family members were infected. Adding another layer of protection. academic.oup.com/cid/advance-ar… @NCICancer
Our work at COVIDhge showed 🧬mutations or auto-Abs to type I IFN caused severe COVID, suggesting IFN could be used against COVID. Now, an RCT proves IFN📉 COVID👇🏼: Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients academic.oup.com/cid/article/do…
Starting now @NCICancer Fungal Symposium with Prof Kontoyiannis speaking! A difficult case with proptosis with fungal elements. I know it’s Halloween in the US but having Dimitrios speak is a real treat ! 👻🎃@NCICancer @PergamIC @JulianLindsay_ @IchsGlobal @monicaslavin
Final Countdown ⏰: Just 3 days to the Annual NCIC Symposium! Join us in-person or online to hear world leading experts discuss 'Tackling #Fungal #Infections: Novel #Immune and #Diagnostic Approaches.' Link to registration in the section below 👇
fredhutch.org/content/www/en… via @fredhutch With increasing infectious disease threats plus a growing population of people with weakened immune systems, we think the time is right to establish a national network dedicated to trials at this intersection.
#ICHSglobal now had country ambassadors to disseminate information about #immunocompromised host information throughout the world. Welcome them!
【The heterogeneous syndrome of non-infectious causes of persistent fever in neutropenic patients with hematologic malignancy: another opportunity for stewardship?】@CIDJournal Oct 14, 2024 👉Useful table for the differential diagnosis of persistent fever in neutropenic fever by…
Secondary antiviral prophylaxis after treatment of CMV infection and disease: systematic review and metaanalysis doi.org/10.1111/tid.14…
Thanks @GermHunterMD this is an important paper. Please read. EORTC/MSGERC criteria on host factors, repeat molecular testing , excluded these patients from meeting IA definitions - they have similar high mortality @NCICancer @monicaslavin
Final Countdown ⏰: Just 3 days to the Annual NCIC Symposium! Join us in-person or online to hear world leading experts discuss 'Tackling #Fungal #Infections: Novel #Immune and #Diagnostic Approaches.' Link to registration in the section below 👇
Great to be here with @ChemalyRoy @banhocktan - we talk about challenges and controversies in CMV at APBMT. @IchsGlobal @NCICancer
United States Trends
- 1. Iowa 25.4K posts
- 2. Dante Moore 2,557 posts
- 3. Indiana 40.8K posts
- 4. Penn State 24.8K posts
- 5. Mendoza 22.1K posts
- 6. Heisman 10.4K posts
- 7. Gus Johnson 7,622 posts
- 8. #UFCVegas111 7,405 posts
- 9. Mizzou 4,732 posts
- 10. Atticus Sappington N/A
- 11. Sayin 70.8K posts
- 12. #GoDucks 2,387 posts
- 13. Sounders N/A
- 14. #kufball N/A
- 15. UConn 4,121 posts
- 16. Cam Coleman N/A
- 17. #iufb 4,628 posts
- 18. Fran Brown N/A
- 19. Preston Howard N/A
- 20. Barcelos 1,071 posts
You might like
-
NCIC
@NCICancer -
ICHS-Global
@IchsGlobal -
Raymund Razonable
@RazonableMD -
Abhay Dhand
@DhandAbhay -
Hans H Hirsch
@HansHHirsch1 -
Lara Danziger-Isakov
@ldanzigerisakov -
Dr David Griffin 🦠🧫💉
@drdavidwjg -
Priya Kodiyanplakkal, MD
@rk3 -
Dr Roy Chemaly
@ChemalyRoy -
Adam Stewart
@adm_stewart -
shahid.husain@tid
@shahidh80523771 -
Ann Woolley
@AnnWoolleyMD -
genovefa papanicolaou
@GenPapaMD -
camwolfe
@camwolfe
Something went wrong.
Something went wrong.